Dublin, April 26, 2022 (GLOBE NEWSWIRE) -- The "Intraosseous Infusion Devices Market, by Product Type, by Technology, by End User, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2021 ...

Potential Savings of $95 Million Annually if Only Ten Percent of Central Lines Are Replaced with IO Access Success rate of 96% in establishing vascular access on first attempt; Mean time to vascular ...

In patients with out-of-hospital cardiac arrest, the effectiveness of drugs such as epinephrine is highly time-dependent. An intraosseous route of drug administration may enable more rapid drug ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio Intraosseous delivery of vancomycin after ...

In the PARAMEDIC-3 trial conducted in the U.K., the 30-day survival rate was 4.5% when the first attempt at access was intraosseous and 5.1% with the intravenous-first strategy (adjusted OR 0.94, 95% ...

Dublin, April 15, 2022 (GLOBE NEWSWIRE) -- The "Intraosseous Devices Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts ...

DUBLIN, April 14, 2022 /PRNewswire/ -- The 'Intraosseous Devices market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, ...